Navigation Links
BioMarin Announces Fourth Quarter and Full Year 2010 Financial Results
Date:2/17/2011

The company expects to enroll approximately 160 patients across 40 centers worldwide.
  • Kuvan Outcomes Study: PKU-016, a randomized, placebo-controlled, 13-week Kuvan outcomes study is ongoing.  Endpoints include clinically validated measures of neuropsychiatric symptoms and if successful, may enable a label amendment.  
  • Hand-Held Blood Phe Monitor: Several other programs are underway to expand and protect the market and to improve the ability of healthcare providers and patients to better manage PKU.  These programs include a state-of-the-art handheld device to measure blood Phe levels in PKU patients. Regulatory approval and commercial availability of the handheld blood Phe monitor are expected in late 2011.
  • Firdapse: BioMarin expects to initiate a Phase III trial for LEMS in the U.S. in the second quarter of 2011.  If successful, NDA submission is expected in the first half of 2012, followed by approval by the end of 2012.

  • Mid-Stage Clinical Programs

  • PEG-PAL for PKU: Top-line results for the Phase II study, including a study comparing daily and weekly dosing and a formulation study are expected in mid-2011.  The company expects to initiate a Phase III trial in the first quarter of 2012.

  • Early-Stage Clinical Programs

  • BMN-673 (PARP inhibitor):  The company initiated a Phase I/II trial in January 2011.  The trial is an open-label study of once daily, orally administered BMN-673 in up to 70 patients ages 18 and older with advanced or recurrent solid tumors.  The primary objective of the study is to establish the maximum tolerated dose of daily oral BMN-673 and to obtain preliminary efficacy data in an expanded cohort of patients with genetically-defined tumors.
  • BMN-701 for Pompe Disease: BioMarin initiated a Phase I/II trial in Pompe patients in January 2011.  The trial is an open-label study to ev
    '/>"/>

  • SOURCE BioMarin Pharmaceutical Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. BioMarin Initiates Pivotal Phase 3 Trial for GALNS for the Treatment of MPS IVA
    2. BioMarin to Host Fourth Quarter and Full Year 2010 Financial Results
    3. BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease
    4. BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers
    5. BioMarin to Present at the J.P. Morgan 29th Annual Healthcare Conference
    6. BioMarin to Present at the Deutsche Bank 2010 BioFEST Conference
    7. BioMarin Completes Partial Exchange of Convertible Notes Due 2013 for Common Stock
    8. BioMarin Announces Third Quarter 2010 Financial Results
    9. BioMarin to Host a Research and Development Day on October 19th
    10. BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
    11. BioMarin to Present at the UBS Global Life Sciences Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/4/2015)... 2015 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... and Chief Executive Officer, Doug Godshall , is ... Growth Conference at 8:30 a.m. EDT on Thursday, August ... 2015 at the InterContinental Boston. A live ...
    (Date:8/4/2015)... Research and Markets ... the "MRI Systems Market to 2020 - ... Growth Driven by Developing Economies" report to ... 2020 - Focus on Patient Comfort and Operational ... the market, competitive landscape, and trends for three ...
    (Date:8/4/2015)... 2015  Dr. Keesha Ewers of ... approval of flibanserin, or what is being touted ... of decreased female sexual desire back several decades. ... and addressing libido as a singular symptom with ... Photo - ...
    Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5
    ... Vical Incorporated,(Nasdaq: VICL ) today announced ... independently produced video report featuring metastatic,melanoma patients treated ... is expected to be used,broadly by stations in ... Allovectin-7(R) trial, and in other cities by stations ...
    ... III Results Demonstrate Superior Reduction in In-Segment Late Loss, Non-Inferiority in ... ... V Compared to TAXUS, ABBOTT PARK, Ill., April ... Association (JAMA) demonstrated,that use of Abbott,s XIENCE(TM) V Everolimus Eluting Coronary ...
    Cached Medicine Technology:Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 2Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 3Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 4Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 5Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 2Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 3Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 4Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 5
    (Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... to Los Angeles commercial customers. Finding reliable hardware can be difficult and ... When putting an office together or designing a new facility, it is ...
    (Date:8/4/2015)... ... , ... Angelina Jolie is in it at age 39. “It” is menopause, ... Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the Southwest’s leading ... menopause. , Myth #1: Menopause only affects old ladies. – Menopause can affect ...
    (Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... General of the United States, Richard Carmona, M.D., M.P.H., FACS, to its Board ... medication errors and will save lives," Dr. Carmona said. "I strongly believe in ...
    (Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... School is ... summer in the sun and preparing for the back-to-school scramble. Dublin, OH family ... is the best time for the annual dental checkup. In fact, the dentist recently ...
    (Date:8/4/2015)... Thailand (PRWEB) , ... August 04, 2015 , ... ... United Kingdom and other international locations have shown a rise in binge drinking ... consistent link between binge drinking and depression, are continuing to examine trends and ...
    Breaking Medicine News(10 mins):Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3
    ... Plastic and Reconstructive Surgeon Kouros Azar, M.D. offers his ... Safety Awareness Week from March 8 to 14, 2009 sponsored ... safety and comfort are paramount to Dr. Azar , ... facilities located at 425 Haaland Drive, Suite 200 in Thousand ...
    ... of US citizens travel to Mexico for cancer treatment, ... is much less expensive, says TMD Unlimited, a medical ... Chronic Lymphocytic Leukemia (CLL), he went to three different ... In telling their story, the Teeters hope to help ...
    ... , , FRIDAY, March 13 (HealthDay News) -- Most kidney ... technique that eliminates the need for surgery, a pair ... findings have prompted the researchers to claim that the ... standard" of treatment for kidney cancer -- although not ...
    ... help women to take control of their health by ... Commission for Women and First Lady Judge Marjorie O. ... Wellness Guide kiosks in two Philadelphia-area Acme Markets. "Women ... themselves, and their own health ends up low on ...
    ... The human brain,s sensitivity to unexpected outcomes plays a ... behaviors, according to a new study by a team of ... a computer-based card game and microelectrodes to observe neuronal activity ... the journal Science , suggests that neurons in the ...
    ... the only Minnesota hospitals to receive designation ROCHESTER, Minn., ... Surgical Quality Improvement Program (ACS NSQIP) has recognized Mayo ... of the 26 ACS NSQIP participating hospitals in the ... patient care. As a participant in ACS NSQIP, Mayo ...
    Cached Medicine News:Health News:Kouros Azar, M.D. (doctorazar.com), Noted Plastic and Reconstructive Surgeon, Offers Top 10 Tips to Patients to Help Celebrate National Patient Safety Awareness Week 2Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 2Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 3Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 4Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 5Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 6Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 7Health News:Freezing Kidney Cancers Shows Promise 2Health News:Freezing Kidney Cancers Shows Promise 3Health News:PA Commission For Women Kiosk Helps Women Access Health Information 2Health News:University of Pennsylvania researchers find that the unexpected is a key to human learning 2Health News:American College of Surgeons Recognizes Mayo Hospitals for Exemplary Outcomes 2Health News:American College of Surgeons Recognizes Mayo Hospitals for Exemplary Outcomes 3
    0.5% Yeast Extract, 2.0% Tryp, 10mM Sodium Chloride, 2.5mM Potassium Chloride, 10mM Magnesium Chloride, 10mM Mag. Sulfate....
    ... rHead Radial Implant System provides todays ... to radial head replacement. Modular ... patient anatomy while minimizing ligamentous and ... designed alignment guide assists in both ...
    For connection to the bipolar output of electrosurgical generators....
    This table has adjustable height, an integral leg, and blade post. Includes a standard 2" (5 cm) pad....
    Medicine Products: